© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Jupiter Neurosciences, Inc. (JUNS) shows an Average True Range (ATR) of 0.09 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 107.91K, indicating liquidity. These fundamental metrics provide insight into JUNS's underlying financial health and market activity.
Jupiter Neurosciences, Inc. (JUNS) technical indicators as of December 22, 2025: the SMA 20 is -5.15%, SMA 50 at -16.87%, and SMA 200 at -5.72%. The RSI 14 value is 39.2, suggesting its current momentum. These technical analysis signals help assess JUNS's price trends and potential future movements.
Jupiter Neurosciences, Inc. (JUNS) stock performance overview as of December 22, 2025: The 52-week high is $12.812 (currently -94.36% below), and the 52-week low is $0.51 (currently 115.69% above). Over the past year, JUNS's performance is -90.99%, compared to the S&P 500's 12.87% change.
According to market data, Jupiter Neurosciences, Inc. (JUNS) stock's recent performance metrics show that over the last month, JUNS is -12%, with a Year-to-Date (YTD) performance of -89.72%. Over the past year, the stock has seen a -90.99% change. These figures summarize JUNS's price movements across various periods, reflecting its historical returns.
According to current financial data, JUNS stock's P/E (TTM) ratio is -4.93, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for JUNS, including P/S (N/A), P/B (652.14), and P/FCF (-5.62), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.